OFFICIAL-SOURCE RECALL · CANADA
TZIELD (teplizumab) and the Viral Reactivation Recall: communication TZIELD (teplizumab) and the Risk of
Use the identifiers printed on your item to determine whether this recall may affect the product you own.
CHECK THE ITEM YOU OWN
Is your product affected?
- Brand
- See official notice
- Product
- TZIELD (teplizumab) and the Risk of Viral Reactivation
- Manufacturer
- See official notice
The barcode may identify the product type, while the recall may apply only to certain lots, dates or variants. Check all identifiers listed in the official recall.
Why this product was recalled
communication TZIELD (teplizumab) and the Risk of Viral Reactivation Last updated 2026-09-14 Summary Product TZIELD, teplizumab for injection, 2 mg per 2 mL (1 mg/mL) for intravenous infusion Issue Health products - New safety information Health products - Adverse reaction Health products - Product safety What to do See Key Messages below Audience Health professionals Distribution National
Hazard
communication TZIELD (teplizumab) and the Risk of Viral Reactivation Last updated 2026-09-14 Summary Product TZIELD, teplizumab for injection, 2 mg per 2 mL (1 mg/mL) for intravenous infusion Issue Health products - New safety information Health products - Adverse reaction Health products - Product safety What to do See Key Messages below Audience Health professionals Distribution National
Official recall notice
TZIELD (teplizumab) and the Risk of Viral Reactivation
Agency: Health Canada
Official publication date: September 14, 2026
Read the official CANADA_HEALTH recall notice →SCAN ONCE. KEEP WATCHING.
Keep an eye on the products at home.
Scan food and household product barcodes, save your items and get notified when a future recall may match.
